PSEN1 and Alzheimer disease: This method can thus allow for more accurate and efficient editing, with fewer off-target effects, making it especially valuable for correcting the subtle genetic mutations associated with AD, such as those in the APP or PSEN1 genes (Chen and Liu, 2023; Rottner et al., 2025).